Characterization of murine macrophages from bone marrow, spleen and peritoneum
Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular source...
Saved in:
Published in | BMC immunology Vol. 14; no. 1; p. 6 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
05.02.2013
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2172 1471-2172 |
DOI | 10.1186/1471-2172-14-6 |
Cover
Loading…
Abstract | Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared.
We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β.
Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. |
---|---|
AbstractList | Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-[alpha]), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-[beta]). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-[alpha]) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-[beta]. Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Doc number: 6 Abstract Background: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. Results: We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β. Conclusions: Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared.BACKGROUNDMacrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared.We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β.RESULTSWe found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β.Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use.CONCLUSIONSOur results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β. Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Background: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. Results: We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-[alpha]), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-[beta]). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-[alpha]) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-[beta]. Conclusions: Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. BACKGROUND: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. RESULTS: We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β. CONCLUSIONS: Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Abstract Background Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. Results We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-α), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-β). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-α) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-β. Conclusions Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Background Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been performed on macrophages derived from bone marrow, spleen and peritoneum. However, differences among macrophages from these particular sources remain unclear. In this study, the features of murine macrophages from bone marrow, spleen and peritoneum were compared. Results We found that peritoneal macrophages (PMs) appear to be more mature than bone marrow derived macrophages (BMs) and splenic macrophages (SPMs) based on their morphology and surface molecular characteristics. BMs showed the strongest capacity for both proliferation and phagocytosis among the three populations of macrophage. Under resting conditions, SPMs maintained high levels of pro-inflammatory cytokines expression (IL-6, IL-12 and TNF-[alpha]), whereas BMs produced high levels of suppressive cytokines (IL-10 and TGF-[beta]). However, SPMs activated with LPS not only maintained higher levels of (IL-6, IL-12 and TNF-[alpha]) than BMs or PMs, but also maintained higher levels of IL-10 and TGF-[beta]. Conclusions Our results show that BMs, SPMs and PMs are distinct populations with different biological functions, providing clues to guide their further experimental or therapeutic use. Keywords: Macrophage, Bone marrow, Spleen, Peritoneum |
ArticleNumber | 6 |
Audience | Academic |
Author | Wang, Changqi Tan, Thian Kui Harris, David CH Zhao, Ye Cao, Qi Wang, Ya Zheng, Guoping Yu, Xiao Wang, Yiping Zhao, Hong |
AuthorAffiliation | 1 Centre for Transplant and Renal Research at Westmead, Sydney, NSW, Australia 3 Department of Biochemistry and Molecular Biology, Shanxi Medical University, Shanxi, PR China 2 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China |
AuthorAffiliation_xml | – name: 3 Department of Biochemistry and Molecular Biology, Shanxi Medical University, Shanxi, PR China – name: 2 Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China – name: 1 Centre for Transplant and Renal Research at Westmead, Sydney, NSW, Australia |
Author_xml | – sequence: 1 givenname: Changqi surname: Wang fullname: Wang, Changqi – sequence: 2 givenname: Xiao surname: Yu fullname: Yu, Xiao – sequence: 3 givenname: Qi surname: Cao fullname: Cao, Qi – sequence: 4 givenname: Ya surname: Wang fullname: Wang, Ya – sequence: 5 givenname: Guoping surname: Zheng fullname: Zheng, Guoping – sequence: 6 givenname: Thian Kui surname: Tan fullname: Tan, Thian Kui – sequence: 7 givenname: Hong surname: Zhao fullname: Zhao, Hong – sequence: 8 givenname: Ye surname: Zhao fullname: Zhao, Ye – sequence: 9 givenname: Yiping surname: Wang fullname: Wang, Yiping – sequence: 10 givenname: David CH surname: Harris fullname: Harris, David CH |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23384230$$D View this record in MEDLINE/PubMed |
BookMark | eNqFk8tv1DAQxiNURB9w5YgicQGJFDu2E-eCtFrxWKkCicfZmjjjXa-SeLETaPnr8e6WbVOoUA62Zn7zeTTf5DQ56l2PSfKUknNKZfGa8pJmOS3zjPKseJCcHAJHt-7HyWkIa0JoKXP5KDnOGZM8Z-Qk-ThfgQc9oLe_YLCuT51Ju9HbHtMOtHebFSwxpMa7Lq3dLuq9-_kqDZsWsU-hb9JNrB5ibuweJw8NtAGfXJ9nybd3b7_OP2QXn94v5rOLrC55PmRcs7oqdSFIxStGioYjrwCFMURg3QChRhJScGME5lJwUwNSXeZGcCaJNuwsWex1GwdrtfE2dnWlHFi1Czi_VOAHq1tUqAEqrXVdC8KBSJAVoQwFIIBhUEStN3utzVh32GjsBw_tRHSa6e1KLd0PxUTJpSBRYLYXqK27R2Ca0a5TW2_U1pt4U9smXlw34d33EcOgOhs0ti306MagKCviYxVl_P9oLmVViVyIiD6_g67d6PvozI4iBYvkDbWEOC_bGxe71FtRNROMiyK6VEbq_B9U_BrsrI7uGxvjk4KXk4LIDHg5LGEMQS2-fJ6yz257cJjdn0W9eT2uZAgezQGhRG3_hL8Hyu8UaDvsNjy2bdv7yn4DuUEKIg |
CitedBy_id | crossref_primary_10_1016_j_phrs_2018_06_022 crossref_primary_10_1158_1535_7163_MCT_17_0998 crossref_primary_10_1186_s40478_021_01227_1 crossref_primary_10_1016_j_heliyon_2024_e36340 crossref_primary_10_1080_08923973_2016_1202960 crossref_primary_10_1093_infdis_jiy675 crossref_primary_10_1186_s12974_024_03271_9 crossref_primary_10_3390_nu15122750 crossref_primary_10_5966_sctm_2015_0141 crossref_primary_10_1002_path_4630 crossref_primary_10_1016_j_celrep_2020_108325 crossref_primary_10_1371_journal_pbio_3000044 crossref_primary_10_7717_peerj_19039 crossref_primary_10_3390_microorganisms9112311 crossref_primary_10_3389_fimmu_2021_722469 crossref_primary_10_1016_j_neuint_2020_104924 crossref_primary_10_1111_imcb_12305 crossref_primary_10_1111_jnc_15255 crossref_primary_10_4049_jimmunol_2000490 crossref_primary_10_3390_cancers14153613 crossref_primary_10_1016_j_ymeth_2016_09_005 crossref_primary_10_1016_j_vetimm_2018_11_004 crossref_primary_10_1016_j_yexcr_2016_02_004 crossref_primary_10_1111_febs_15683 crossref_primary_10_1016_j_micpath_2023_106294 crossref_primary_10_1152_ajprenal_00538_2017 crossref_primary_10_1038_s41598_018_37329_5 crossref_primary_10_1371_journal_pone_0184626 crossref_primary_10_3390_cancers15225472 crossref_primary_10_1016_j_ejphar_2024_177059 crossref_primary_10_1038_s41420_018_0043_8 crossref_primary_10_1111_jcmm_15005 crossref_primary_10_1016_j_imlet_2017_07_011 crossref_primary_10_1016_j_actbio_2014_07_033 crossref_primary_10_1021_acsnano_7b05465 crossref_primary_10_1007_s00401_019_01992_3 crossref_primary_10_1039_D3FO04026G crossref_primary_10_1016_j_yexcr_2016_08_022 crossref_primary_10_18632_aging_206124 crossref_primary_10_1080_17435390_2018_1537410 crossref_primary_10_1155_2018_7501985 crossref_primary_10_1016_j_jacc_2018_05_061 crossref_primary_10_1016_j_jbc_2022_102193 crossref_primary_10_1080_08820139_2020_1787436 crossref_primary_10_1021_acsnano_1c00114 crossref_primary_10_1038_srep28978 crossref_primary_10_1292_jvms_18_0250 crossref_primary_10_1016_j_molimm_2020_11_001 crossref_primary_10_1186_1743_7075_11_51 crossref_primary_10_3389_fimmu_2017_01919 crossref_primary_10_1007_s00109_020_01923_w crossref_primary_10_3389_fimmu_2022_914956 crossref_primary_10_1073_pnas_2000943117 crossref_primary_10_12688_wellcomeopenres_16061_1 crossref_primary_10_3390_cells9020429 crossref_primary_10_1021_acsabm_0c00529 crossref_primary_10_1007_s00441_016_2491_x crossref_primary_10_1111_eci_12675 crossref_primary_10_1016_j_cyto_2023_156138 crossref_primary_10_1016_j_cellimm_2025_104917 crossref_primary_10_1073_pnas_1614035114 crossref_primary_10_1021_acsinfecdis_4c00192 crossref_primary_10_1002_JLB_1A0119_017R crossref_primary_10_1016_j_ijbiomac_2022_12_127 crossref_primary_10_1371_journal_pone_0292757 crossref_primary_10_3389_fimmu_2023_1274147 crossref_primary_10_1016_j_bioactmat_2024_04_004 crossref_primary_10_1016_j_peptides_2022_170893 crossref_primary_10_1016_j_mex_2018_11_014 crossref_primary_10_1177_1753425917697806 crossref_primary_10_3389_fcimb_2024_1457323 crossref_primary_10_1016_j_resmic_2017_03_003 crossref_primary_10_1186_s12917_021_02746_8 crossref_primary_10_1038_aps_2017_124 crossref_primary_10_1038_srep25481 crossref_primary_10_1038_s41598_018_36969_x crossref_primary_10_1016_j_cellimm_2015_12_005 crossref_primary_10_3389_fimmu_2024_1357340 crossref_primary_10_1080_1547691X_2017_1414339 crossref_primary_10_1096_fj_201901480RR crossref_primary_10_13181_mji_v28i1_1961 crossref_primary_10_3389_fimmu_2024_1527088 crossref_primary_10_1111_aji_12424 crossref_primary_10_1016_j_jcmgh_2022_01_015 crossref_primary_10_1016_j_jim_2017_10_004 crossref_primary_10_26508_lsa_202000865 crossref_primary_10_4014_jmb_2211_11056 crossref_primary_10_3389_fimmu_2015_00225 crossref_primary_10_1016_j_ijbiomac_2019_08_039 crossref_primary_10_1016_j_intimp_2020_106964 crossref_primary_10_1186_s12974_023_02998_1 crossref_primary_10_1016_j_micpath_2017_11_028 crossref_primary_10_1016_j_tube_2015_09_005 crossref_primary_10_1371_journal_pone_0125961 crossref_primary_10_1007_s12016_015_8514_7 crossref_primary_10_1016_j_freeradbiomed_2018_09_031 crossref_primary_10_1111_cmi_12580 crossref_primary_10_1371_journal_pone_0319610 crossref_primary_10_1007_s12026_019_09083_x crossref_primary_10_3389_fimmu_2017_01629 crossref_primary_10_1038_s41598_019_56305_1 crossref_primary_10_3390_cells9112406 crossref_primary_10_1016_j_cpme_2018_06_001 crossref_primary_10_1016_j_ejphar_2017_07_022 crossref_primary_10_1016_j_expneurol_2020_113461 crossref_primary_10_1165_rcmb_2019_0200OC crossref_primary_10_1186_s12974_024_03032_8 crossref_primary_10_1152_ajpgi_00121_2017 crossref_primary_10_1111_tri_12789 crossref_primary_10_1016_j_micpath_2017_05_028 crossref_primary_10_1021_acs_nanolett_8b00689 crossref_primary_10_3389_fimmu_2018_00169 crossref_primary_10_3390_ijms22073532 crossref_primary_10_1038_kisup_2014_4 crossref_primary_10_1016_j_bbalip_2020_158654 crossref_primary_10_1038_s41467_020_17669_5 crossref_primary_10_1371_journal_pone_0156626 crossref_primary_10_1016_j_mex_2020_101027 crossref_primary_10_1007_s00011_023_01834_9 crossref_primary_10_1016_j_imbio_2015_06_018 crossref_primary_10_3389_fvets_2023_1256284 crossref_primary_10_3389_fbiom_2024_1399448 crossref_primary_10_1128_JVI_00216_14 crossref_primary_10_1016_j_molcel_2016_12_025 crossref_primary_10_3389_fimmu_2020_00269 crossref_primary_10_1080_15548627_2019_1703353 crossref_primary_10_1371_journal_pone_0176324 crossref_primary_10_3389_fgene_2018_00526 crossref_primary_10_1038_s41467_019_13636_x crossref_primary_10_1093_brain_awab203 crossref_primary_10_1186_s12864_019_5450_6 crossref_primary_10_3389_fimmu_2024_1466692 crossref_primary_10_1017_S0007114514002554 crossref_primary_10_1177_1753425916681444 crossref_primary_10_1038_s41598_017_07397_0 crossref_primary_10_3389_fimmu_2023_1122057 crossref_primary_10_1186_s13287_019_1405_8 crossref_primary_10_1128_IAI_00738_20 crossref_primary_10_1186_s12865_017_0223_y crossref_primary_10_3389_fcimb_2019_00286 crossref_primary_10_1080_08820139_2023_2173077 crossref_primary_10_1016_j_intimp_2023_110297 crossref_primary_10_1096_fj_201901684RR crossref_primary_10_1016_j_bioactmat_2022_07_021 crossref_primary_10_1016_j_neuint_2019_104480 crossref_primary_10_1002_2211_5463_12262 crossref_primary_10_1002_adfm_202110179 crossref_primary_10_1007_s11010_022_04390_8 crossref_primary_10_1007_s00430_015_0403_4 crossref_primary_10_3390_cancers13164081 crossref_primary_10_1016_j_ijbiomac_2022_07_001 crossref_primary_10_1016_j_tox_2017_01_001 crossref_primary_10_3389_fphar_2018_00985 |
Cites_doi | 10.1189/jlb.72.4.621 10.1016/S0923-2494(99)80039-X 10.1002/jlb.47.6.490 10.1084/jem.158.5.1522 10.1046/j.0009-9104.2002.01977.x 10.1242/jcs.101.4.907 10.1016/S0002-9440(10)62990-2 10.1182/blood-2002-02-0569 10.1186/1471-2172-10-18 10.1016/j.jim.2008.07.009 10.2174/1568010054022042 10.4049/jimmunol.134.2.982 10.1002/jcp.20732 10.1681/ASN.2010030269 10.1186/1471-2172-4-5 10.1016/j.biomaterials.2012.02.034 10.1016/j.coi.2004.12.004 10.1158/0008-5472.CAN-05-1299 10.1159/000321034 10.1084/jem.41.3.399 10.1371/journal.pone.0015263 10.1161/01.CIR.102.24.2919 10.1002/eji.200737638 10.1038/cmi.2009.50 10.1681/ASN.2010070693 10.1093/intimm/dxl034 10.1111/j.1365-3083.1987.tb02301.x 10.1002/eji.1830111013 10.1002/jlb.41.4.295 10.1002/eji.1830090410 10.1007/978-1-4684-4394-3_26 10.1038/ni1104-1105 10.1128/IAI.61.4.1468-1473.1993 10.1681/ASN.2011070680 10.1016/0008-8749(92)90011-D 10.1016/S0022-2275(20)34934-8 10.1189/jlb.72.1.101 10.2353/ajpath.2008.070825 10.1002/eji.200737042 10.1084/jem.20070075 10.1016/j.crvi.2004.04.005 10.1126/science.1178331 10.1073/pnas.0908641106 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2013 BioMed Central Ltd. 2013 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2013 Wang et al.; licensee BioMed Central Ltd. 2013 Wang et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2013 BioMed Central Ltd. – notice: 2013 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2013 Wang et al.; licensee BioMed Central Ltd. 2013 Wang et al.; licensee BioMed Central Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7T5 7X7 7XB 88E 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/1471-2172-14-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Science (Gale in Context) ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1471-2172 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_ecaa9cccbb504a08a89013e5aeaaf3a6 PMC3574850 oai_biomedcentral_com_1471_2172_14_6 2893092231 A534560947 23384230 10_1186_1471_2172_14_6 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Australia |
GeographicLocations_xml | – name: Australia |
GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5VS 6J9 7X7 88E 8C1 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7T5 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 -A0 ABVAZ ACRMQ ADINQ AFGXO AFNRJ C24 5PM PUEGO |
ID | FETCH-LOGICAL-b742t-4c3b97c650949306d4e49ae5ff05ebda01f80064ff5e2854fbae1c72f54380cf3 |
IEDL.DBID | RBZ |
ISSN | 1471-2172 |
IngestDate | Wed Aug 27 01:31:41 EDT 2025 Thu Aug 21 13:42:20 EDT 2025 Wed May 22 07:14:43 EDT 2024 Fri Jul 11 07:03:59 EDT 2025 Tue Aug 05 10:58:37 EDT 2025 Fri Jul 25 19:23:41 EDT 2025 Tue Jun 17 22:05:17 EDT 2025 Tue Jun 10 21:00:50 EDT 2025 Fri Jun 27 05:57:47 EDT 2025 Thu Apr 03 07:00:30 EDT 2025 Tue Jul 01 03:29:35 EDT 2025 Thu Apr 24 23:12:04 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b742t-4c3b97c650949306d4e49ae5ff05ebda01f80064ff5e2854fbae1c72f54380cf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | http://dx.doi.org/10.1186/1471-2172-14-6 |
PMID | 23384230 |
PQID | 1288063899 |
PQPubID | 44823 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ecaa9cccbb504a08a89013e5aeaaf3a6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3574850 biomedcentral_primary_oai_biomedcentral_com_1471_2172_14_6 proquest_miscellaneous_1367489134 proquest_miscellaneous_1288995255 proquest_journals_1288063899 gale_infotracmisc_A534560947 gale_infotracacademiconefile_A534560947 gale_incontextgauss_ISR_A534560947 pubmed_primary_23384230 crossref_primary_10_1186_1471_2172_14_6 crossref_citationtrail_10_1186_1471_2172_14_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-02-05 |
PublicationDateYYYYMMDD | 2013-02-05 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC immunology |
PublicationTitleAlternate | BMC Immunol |
PublicationYear | 2013 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | Y Wang (495_CR34) 2008; 172 D Ruffell (495_CR33) 2009; 106 A Alatery (495_CR26) 2008; 338 G Kraal (495_CR12) 1987; 26 R Andreesen (495_CR27) 1990; 47 FM Marim (495_CR24) 2010; 5 P Isomaki (495_CR41) 2005; 4 YS Baek (495_CR21) 2009; 10 YN Zhu (495_CR8) 2006; 18 Y Wang (495_CR28) 2009; 6 NA Mitchison (495_CR38) 1969; 16 DA Hume (495_CR11) 1983; 158 DA Hume (495_CR18) 1982; 155 AL Millard (495_CR44) 2002; 130 Y Wang (495_CR17) 2011; 22 D Zheng (495_CR37) 2011; 118 S Gordon (495_CR1) 2007; 37 BN Brown (495_CR31) 2012; 33 DA Hume (495_CR3) 2002; 72 G Liu (495_CR7) 2006; 209 JG Kim (495_CR14) 1997; 38 S Gordon (495_CR19) 1998; 149 JM Austyn (495_CR10) 1981; 11 KJ Goodrum (495_CR20) 1987; 41 SH Kaufmann (495_CR6) 2005; 17 X Zhou (495_CR40) 2000; 102 PJ Nelson (495_CR32) 2012; 23 GJ Cannon (495_CR39) 1992; 101 CA Wells (495_CR22) 2003; 4 F Geissmann (495_CR25) 2010; 327 L Arnold (495_CR30) 2007; 204 RT Sasmono (495_CR2) 2003; 101 P Rous (495_CR5) 1925; 41 T Springer (495_CR9) 1979; 9 Q Cao (495_CR35) 2009 X Yang (495_CR15) 2000; 16 Q Cao (495_CR36) 2011; 22 B Huang (495_CR29) 2006; 66 MG Petroff (495_CR42) 2005; 167 W Xu (495_CR46) 2007; 37 E Galligioni (495_CR48) 1995; 1 K Shortman (495_CR4) 2004; 5 J Weischenfeldt (495_CR23) 2008; 2008 S Gordon (495_CR16) 2004; 327 TE Lane (495_CR13) 1993; 61 MK Gately (495_CR47) 1992; 143 CF Anderson (495_CR43) 2002; 72 MK Warren (495_CR45) 1985; 134 19805133 - Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17475-80 17474153 - Eur J Immunol. 2007 Jun;37(6):1594-9 89034 - Eur J Immunol. 1979 Apr;9(4):301-6 16101535 - Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):287-93 21719780 - J Am Soc Nephrol. 2011 Jul;22(7):1229-39 16883572 - J Cell Physiol. 2006 Nov;209(2):341-52 17485518 - J Exp Med. 2007 May 14;204(5):1057-69 19887052 - Cell Mol Immunol. 2009 Oct;6(5):387-92 11045296 - Adv Perit Dial. 2000;16:213-5 20133564 - Science. 2010 Feb 5;327(5966):656-61 21311199 - Nephron Exp Nephrol. 2011;118(4):e87-99 12377929 - J Leukoc Biol. 2002 Oct;72(4):621-7 19341462 - BMC Immunol. 2009;10:18 16424049 - Cancer Res. 2006 Jan 15;66(2):1123-31 15653315 - Curr Opin Immunol. 2005 Feb;17(1):79-87 17972350 - Eur J Immunol. 2007 Nov;37 Suppl 1:S9-17 6984281 - Adv Exp Med Biol. 1982;155:261-6 21179419 - PLoS One. 2010;5(12):e15263 18467704 - Am J Pathol. 2008 Jun;172(6):1491-9 15496948 - Nat Immunol. 2004 Nov;5(11):1105-6 3471827 - J Leukoc Biol. 1987 Apr;41(4):295-301 5770808 - Immunology. 1969 Jan;16(1):1-14 9816008 - Clin Cancer Res. 1995 May;1(5):493-9 7308288 - Eur J Immunol. 1981 Oct;11(10):805-15 1352483 - Cell Immunol. 1992 Aug;143(1):127-42 1693647 - J Leukoc Biol. 1990 Jun;47(6):490-7 12101268 - J Leukoc Biol. 2002 Jul;72(1):101-6 21209251 - J Am Soc Nephrol. 2011 Jan;22(1):21-7 1527185 - J Cell Sci. 1992 Apr;101 ( Pt 4):907-13 16049332 - Am J Pathol. 2005 Aug;167(2):465-73 3321409 - Scand J Immunol. 1987 Dec;26(6):653-61 2578168 - J Immunol. 1985 Feb;134(2):982-9 12390312 - Clin Exp Immunol. 2002 Nov;130(2):245-55 19868996 - J Exp Med. 1925 Feb 28;41(3):399-411 12393599 - Blood. 2003 Feb 1;101(3):1155-63 12826024 - BMC Immunol. 2003 Jun 26;4:5 22135312 - J Am Soc Nephrol. 2012 Feb;23(2):194-203 15330259 - C R Biol. 2004 Jun;327(6):603-7 11113040 - Circulation. 2000 Dec 12;102(24):2919-22 9392418 - J Lipid Res. 1997 Nov;38(11):2207-15 16636012 - Int Immunol. 2006 Jun;18(6):981-90 18675819 - J Immunol Methods. 2008 Sep 30;338(1-2):47-57 22386919 - Biomaterials. 2012 May;33(15):3792-802 6355361 - J Exp Med. 1983 Nov 1;158(5):1522-36 8454351 - Infect Immun. 1993 Apr;61(4):1468-73 9851524 - Res Immunol. 1998 Sep-Oct;149(7-8):685-8 21356739 - CSH Protoc. 2008 Dec 01;2008:pdb.prot5080 |
References_xml | – volume: 72 start-page: 621 year: 2002 ident: 495_CR3 publication-title: J Leukoc Biol doi: 10.1189/jlb.72.4.621 – volume: 149 start-page: 685 year: 1998 ident: 495_CR19 publication-title: Res Immunol doi: 10.1016/S0923-2494(99)80039-X – volume: 47 start-page: 490 year: 1990 ident: 495_CR27 publication-title: J Leukoc Biol doi: 10.1002/jlb.47.6.490 – volume: 158 start-page: 1522 year: 1983 ident: 495_CR11 publication-title: J Exp Med doi: 10.1084/jem.158.5.1522 – volume: 130 start-page: 245 year: 2002 ident: 495_CR44 publication-title: Clin Exp Immunol doi: 10.1046/j.0009-9104.2002.01977.x – volume: 101 start-page: 907 issue: Pt 4 year: 1992 ident: 495_CR39 publication-title: J Cell Sci doi: 10.1242/jcs.101.4.907 – volume: 167 start-page: 465 year: 2005 ident: 495_CR42 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)62990-2 – volume: 101 start-page: 1155 year: 2003 ident: 495_CR2 publication-title: Blood doi: 10.1182/blood-2002-02-0569 – volume: 10 start-page: 18 year: 2009 ident: 495_CR21 publication-title: BMC Immunol doi: 10.1186/1471-2172-10-18 – volume: 338 start-page: 47 year: 2008 ident: 495_CR26 publication-title: J Immunol Methods doi: 10.1016/j.jim.2008.07.009 – volume: 16 start-page: 1 year: 1969 ident: 495_CR38 publication-title: Immunology – volume: 4 start-page: 287 year: 2005 ident: 495_CR41 publication-title: Curr Drug Targets Inflamm Allergy doi: 10.2174/1568010054022042 – volume: 134 start-page: 982 year: 1985 ident: 495_CR45 publication-title: J Immunol doi: 10.4049/jimmunol.134.2.982 – volume: 209 start-page: 341 year: 2006 ident: 495_CR7 publication-title: J Cell Physiol doi: 10.1002/jcp.20732 – volume: 22 start-page: 21 year: 2011 ident: 495_CR17 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010030269 – volume: 4 start-page: 5 year: 2003 ident: 495_CR22 publication-title: BMC Immunol doi: 10.1186/1471-2172-4-5 – volume: 33 start-page: 3792 year: 2012 ident: 495_CR31 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.02.034 – volume: 17 start-page: 79 year: 2005 ident: 495_CR6 publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2004.12.004 – volume: 66 start-page: 1123 year: 2006 ident: 495_CR29 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1299 – volume: 1 start-page: 493 year: 1995 ident: 495_CR48 publication-title: Clin Cancer Res – volume: 118 start-page: e87 year: 2011 ident: 495_CR37 publication-title: Nephron Exp Nephrol doi: 10.1159/000321034 – volume: 41 start-page: 399 year: 1925 ident: 495_CR5 publication-title: J Exp Med doi: 10.1084/jem.41.3.399 – volume: 5 start-page: e15263 year: 2010 ident: 495_CR24 publication-title: PLoS One doi: 10.1371/journal.pone.0015263 – volume: 102 start-page: 2919 year: 2000 ident: 495_CR40 publication-title: Circulation doi: 10.1161/01.CIR.102.24.2919 – volume: 37 start-page: S9 issue: Suppl 1 year: 2007 ident: 495_CR1 publication-title: Eur J Immunol doi: 10.1002/eji.200737638 – volume: 16 start-page: 213 year: 2000 ident: 495_CR15 publication-title: Adv Perit Dial – volume: 6 start-page: 387 year: 2009 ident: 495_CR28 publication-title: Cell Mol Immunol doi: 10.1038/cmi.2009.50 – volume: 22 start-page: 1229 year: 2011 ident: 495_CR36 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010070693 – volume: 18 start-page: 981 year: 2006 ident: 495_CR8 publication-title: Int Immunol doi: 10.1093/intimm/dxl034 – volume-title: Impaired alternative activated macrophages from bone marrow in treatment of CKD: Associations with their proliferation in inflamed kidney. Presented in abstract form at the annual meeting of the American Society of Nephrology; October 27 through November 1 year: 2009 ident: 495_CR35 – volume: 26 start-page: 653 year: 1987 ident: 495_CR12 publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.1987.tb02301.x – volume: 11 start-page: 805 year: 1981 ident: 495_CR10 publication-title: Eur J Immunol doi: 10.1002/eji.1830111013 – volume: 41 start-page: 295 year: 1987 ident: 495_CR20 publication-title: J Leukoc Biol doi: 10.1002/jlb.41.4.295 – volume: 9 start-page: 301 year: 1979 ident: 495_CR9 publication-title: Eur J Immunol doi: 10.1002/eji.1830090410 – volume: 155 start-page: 261 year: 1982 ident: 495_CR18 publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4684-4394-3_26 – volume: 2008 start-page: pdb prot5080 year: 2008 ident: 495_CR23 publication-title: CSH Protoc – volume: 5 start-page: 1105 year: 2004 ident: 495_CR4 publication-title: Nat Immunol doi: 10.1038/ni1104-1105 – volume: 61 start-page: 1468 year: 1993 ident: 495_CR13 publication-title: Infect Immun doi: 10.1128/IAI.61.4.1468-1473.1993 – volume: 23 start-page: 194 year: 2012 ident: 495_CR32 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2011070680 – volume: 143 start-page: 127 year: 1992 ident: 495_CR47 publication-title: Cell Immunol doi: 10.1016/0008-8749(92)90011-D – volume: 38 start-page: 2207 year: 1997 ident: 495_CR14 publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)34934-8 – volume: 72 start-page: 101 year: 2002 ident: 495_CR43 publication-title: J Leukoc Biol doi: 10.1189/jlb.72.1.101 – volume: 172 start-page: 1491 year: 2008 ident: 495_CR34 publication-title: Am J Pathol doi: 10.2353/ajpath.2008.070825 – volume: 37 start-page: 1594 year: 2007 ident: 495_CR46 publication-title: Eur J Immunol doi: 10.1002/eji.200737042 – volume: 204 start-page: 1057 year: 2007 ident: 495_CR30 publication-title: J Exp Med doi: 10.1084/jem.20070075 – volume: 327 start-page: 603 year: 2004 ident: 495_CR16 publication-title: C R Biol doi: 10.1016/j.crvi.2004.04.005 – volume: 327 start-page: 656 year: 2010 ident: 495_CR25 publication-title: Science doi: 10.1126/science.1178331 – volume: 106 start-page: 17475 year: 2009 ident: 495_CR33 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0908641106 – reference: 19868996 - J Exp Med. 1925 Feb 28;41(3):399-411 – reference: 11113040 - Circulation. 2000 Dec 12;102(24):2919-22 – reference: 6355361 - J Exp Med. 1983 Nov 1;158(5):1522-36 – reference: 2578168 - J Immunol. 1985 Feb;134(2):982-9 – reference: 12101268 - J Leukoc Biol. 2002 Jul;72(1):101-6 – reference: 1352483 - Cell Immunol. 1992 Aug;143(1):127-42 – reference: 19805133 - Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17475-80 – reference: 21719780 - J Am Soc Nephrol. 2011 Jul;22(7):1229-39 – reference: 12377929 - J Leukoc Biol. 2002 Oct;72(4):621-7 – reference: 19341462 - BMC Immunol. 2009;10:18 – reference: 12393599 - Blood. 2003 Feb 1;101(3):1155-63 – reference: 1693647 - J Leukoc Biol. 1990 Jun;47(6):490-7 – reference: 22386919 - Biomaterials. 2012 May;33(15):3792-802 – reference: 21209251 - J Am Soc Nephrol. 2011 Jan;22(1):21-7 – reference: 17485518 - J Exp Med. 2007 May 14;204(5):1057-69 – reference: 6984281 - Adv Exp Med Biol. 1982;155:261-6 – reference: 16883572 - J Cell Physiol. 2006 Nov;209(2):341-52 – reference: 22135312 - J Am Soc Nephrol. 2012 Feb;23(2):194-203 – reference: 18675819 - J Immunol Methods. 2008 Sep 30;338(1-2):47-57 – reference: 21356739 - CSH Protoc. 2008 Dec 01;2008:pdb.prot5080 – reference: 12826024 - BMC Immunol. 2003 Jun 26;4:5 – reference: 16101535 - Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):287-93 – reference: 15330259 - C R Biol. 2004 Jun;327(6):603-7 – reference: 1527185 - J Cell Sci. 1992 Apr;101 ( Pt 4):907-13 – reference: 12390312 - Clin Exp Immunol. 2002 Nov;130(2):245-55 – reference: 3321409 - Scand J Immunol. 1987 Dec;26(6):653-61 – reference: 17972350 - Eur J Immunol. 2007 Nov;37 Suppl 1:S9-17 – reference: 21179419 - PLoS One. 2010;5(12):e15263 – reference: 18467704 - Am J Pathol. 2008 Jun;172(6):1491-9 – reference: 89034 - Eur J Immunol. 1979 Apr;9(4):301-6 – reference: 17474153 - Eur J Immunol. 2007 Jun;37(6):1594-9 – reference: 9816008 - Clin Cancer Res. 1995 May;1(5):493-9 – reference: 16636012 - Int Immunol. 2006 Jun;18(6):981-90 – reference: 3471827 - J Leukoc Biol. 1987 Apr;41(4):295-301 – reference: 16049332 - Am J Pathol. 2005 Aug;167(2):465-73 – reference: 19887052 - Cell Mol Immunol. 2009 Oct;6(5):387-92 – reference: 11045296 - Adv Perit Dial. 2000;16:213-5 – reference: 21311199 - Nephron Exp Nephrol. 2011;118(4):e87-99 – reference: 9851524 - Res Immunol. 1998 Sep-Oct;149(7-8):685-8 – reference: 15496948 - Nat Immunol. 2004 Nov;5(11):1105-6 – reference: 15653315 - Curr Opin Immunol. 2005 Feb;17(1):79-87 – reference: 9392418 - J Lipid Res. 1997 Nov;38(11):2207-15 – reference: 16424049 - Cancer Res. 2006 Jan 15;66(2):1123-31 – reference: 8454351 - Infect Immun. 1993 Apr;61(4):1468-73 – reference: 5770808 - Immunology. 1969 Jan;16(1):1-14 – reference: 20133564 - Science. 2010 Feb 5;327(5966):656-61 – reference: 7308288 - Eur J Immunol. 1981 Oct;11(10):805-15 |
SSID | ssj0017828 |
Score | 2.3980303 |
Snippet | Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies have been... Background Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental studies... Doc number: 6 Abstract Background: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date,... Background: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental... BACKGROUND: Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most experimental... Abstract Background Macrophages have heterogeneous phenotypes and complex functions within both innate and adaptive immune responses. To date, most... |
SourceID | doaj pubmedcentral biomedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 6 |
SubjectTerms | Animals Antigen Presentation - immunology Bone marrow Bone Marrow Cells - cytology Bone morphogenetic proteins CD4-Positive T-Lymphocytes - immunology Cell Membrane - metabolism Cell Proliferation Cell Shape Cells, Cultured Comparative analysis Cytokines - genetics Cytokines - metabolism Dextrans - metabolism Flow Cytometry Fluorescein-5-isothiocyanate - analogs & derivatives Fluorescein-5-isothiocyanate - metabolism Gene Expression Regulation Genotype & phenotype Immune response Lymphocyte Activation - immunology Macrophage Macrophages Macrophages - cytology Macrophages - immunology Macrophages, Peritoneal - cytology Male Mice Mice, Inbred BALB C Nitric oxide Peritoneum Phagocytosis - immunology Phenotype Physiological aspects Proteins RNA, Messenger - genetics RNA, Messenger - metabolism Rodents Spleen Spleen - cytology Statistical methods Studies Transforming growth factors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDI_QJBAXBOOrMFBASFyI1qZJ23AbE9NA2g7ApN2iJE3YpL2-ib534L_HTvOqFybgwq1K3DR1nNhJ7J8JecNBEKyvW8a5l0xIJ5htuWEVb4zwbWmkx-Dkk9Pm-Ex8PpfnW6m-0CdsggeeGLfvnTHKOWetLIUpO9MpPLmTxhsTahPBtkHnbTZT6f4A9F4MgoOll2EKpgTXWHXN_lzGKsGa3-LcrzL1FFH8b67VW8oqd6Tc0kxH98m9ZFLSg-lXHpBbftglt6ckkz93yZ2TdH3-kJwezvDMU_QlXQa6wPN2TxcGk3ldwPIyUow5oXYZSxGj8R0dr9HlgpqhpwiNjAje68Ujcnb08dvhMUsJFYD_gq-YcLVVrYugeQr2Cr3wQhkvQyilt70pq9ChjRKC9BhZGazxlWt5kIhL70L9mOwM8IGnhLa-b5RoPExfJ8BoUY0JIkCDfdX1lbIFeZ_xVV9P4Bka4azzGphZGgdF46DAk24KwjaDoF2CKseMGVc6blm65gb925l-850_UX7AMc16EwtA5HQSOf0vkSvIa5QIjfAZA_rnfDfrcdSfvn7RB7IGixTY20KfElFYQt-dSeEOwD5E3Moo9zJKmN8ur94Ink7ry6jBquiisakK8mquxjfRZ27wy_VEo5SEPeNfaGpMNoPeFwV5MsnyzBte1x0Y22VB2kzKM-blNcPlRUQoryW0Kstn_4Pbz8ldHlOQcFbKPbKz-rH2L8AQXNmXcc7_Aqy5W4E priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9QwDI5gCMQLggGjMFBASLwQrU2TtuEFjRPTQNoegEl7i9I02ZB27bHePfDvsdPcsTCxt1PjSyPbsZ3U_kzIWw6K0LqyZpw7yYS0grU1N6zglRGuzo10WJx8dFwdnoivp_I0XriNMa1ybRODoe4Gi3fke2BHm-Be1cfFL4Zdo_DramyhcZvcKcAGI3Z-M9ukeBTg_ZoI1Fg01V4BhphhQyZWCFb9U-F-kTimgN9_3UpfcVNpCuUVn3TwkDyIwSTdn6T_iNxy_Ta5O7WX_L1N7h3FD-ePyfFsA8w81V3SwdM53rQ7OjfYxuscDMtIsdqEtkN4iuiM7-m4wGQLavqOIigyYnev5k_IycHnH7NDFlspAOcFXzJhy1bVNsDlKTgldMIJZZz0Ppeu7Uxe-AajE--lw5pK3xpX2Jp7iYj01pdPyVYPL3hGaO26SonKgSysgHBFVcYLDxN2RdMVqs3Ih4SvejHBZmgEsk5HQL4ahaJRKPBLVxlhayFoG0HKsVfGhQ6Hlaa6Rv9uQ79-z_8oP6FMk9WEB8PlmY67VDtrjLLWtq3Mhckb0yi8JpbGGeNLA5O8QY3QCJzRY2bOmVmNo_7y_ZvelyXEosDeGtYUifwAa7cmFjoA-xBrK6HcTShhZ9t0eK14OlqWUf_dBxl5vRnGf2K2XO-G1USjlITT4g00JbaZwbyLjOxMurzhDS_LBsLsPCN1ouUJ89KR_ud5wCYvJcwq8-c3L_0Fuc9DWxHOcrlLtpaXK_cSgrtl-yrs4D9WHk7d priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagCNQLgvIKFBQQEhcMiWMnMRJCpaIqSNsDsFJvluPYLdJu0m52JfrvmXGSbc0C4hbFE8eah2eczHxDyEsGilDZrKCMWUG5MJxWBdM0Zbnmtki0sFicPDnKD6f8y7E4vsx_GhjY_fFoh_2kpovZm5_nFx_A4N97gy_ztylssBQbLdGU0_w6uQFeqcA2DhN--UcBPKEvixtpBwDHzed_q3yfBQ7L4_pv7t5X3FeYWnnFVx3cIbeHIDPe67XiLrlmmx1ys287ebFDbk2GH-r3yNH-GrC5r8eMWxfP8Qu8jeca23udwobTxViFEletv4uoja_j7gyTMGLd1DGCJSOm92p-n0wPPn3fP6RDiwWQCGdLyk1WycJ4GD0Jp4eaWy61Fc4lwla1TlJXYtTinLBYa-kqbVNTMCcQqd647AHZauAFj0hc2DqXPLdg0IZDGCNz7biDCeu0rFNZReRdwFd11sNpKAS4DkfA1hQKRaFQ4ErlEaGjEJQZwMuxh8ZM-UNMmW_Qv1rTj-_5G-VHlGmwGn-jXZyowXqVNVpLY0xViYTrpNSlxM_HQlutXaZhkheoEQoBNRrM2DnRq65Tn799VXsigxgV2FvAmgYi18LajR4KIIB9iMEVUO4GlGDxJhweFU-NBqMgzih9-Ckj8nw9jE9iFl1j21VPI6WAU-Q_aDJsP4P5GBF52Ovymjcsy0oIv5OIFIGWB8wLR5ofpx6zPBMwq0ge_w-jnpBt5puOMJqIXbK1XKzsUwj9ltUzb9O_AJ3VVP4 priority: 102 providerName: Scholars Portal |
Title | Characterization of murine macrophages from bone marrow, spleen and peritoneum |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23384230 https://www.proquest.com/docview/1288063899 https://www.proquest.com/docview/1288995255 https://www.proquest.com/docview/1367489134 http://dx.doi.org/10.1186/1471-2172-14-6 https://pubmed.ncbi.nlm.nih.gov/PMC3574850 https://doaj.org/article/ecaa9cccbb504a08a89013e5aeaaf3a6 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYJhAvCMZXYFQBIfGCReLYcczbWm0aSK1QYVLFi-U49oa0phNtH_jvuXPSMq-CF16iKL7Y1t3ZPtt3vyPkLQNFqF0hKWNOUC4sp7VkhuasNNzJzAiHwcnjSXl2zj_PxOzPecetG_y8Kj_kMH1STKNEc07LPXLAuOSYpGE6_L69L4B1LgS9bWh7eMbd_2_FtV9Fy1FA7d-dm28sTrHj5I2V6PQhedCbkOlxJ_NH5I5rD8ndLqnkr0Nyb9xflz8mk9EWjrmLtkwXPp3j-bpL5waTd13CdLJMMcYkrRfhK2Iyvk-X1-hikZq2SREKGRG71_Mn5Pz05NvojPYJFIDfnK0ot0WtpA0geQr2Bg13XBknvM-EqxuT5b5Cm8R74TCS0tfG5VYyLxCH3vriKdlvoYHnJJWuKRUvHQxXy8FIUaXx3EOFTV41uaoT8jHiq77uwDI0wlfHJTCSNApFo1DgTZcJoRshaNtDk2OGjCsdtihVuUP_bku_aedvlEOUadSb8AE0TPdjUztrjLLW1rXIuMkqUyk8HBbGGeMLA5W8QY3QCJfRoj_OhVkvl_rT16k-FgVYoMBeCX3qifwC-m5NH94A7EOErYjyKKKE8Wzj4o3i6X4-WWqwIqpgXKqEvN4W45_oI9e6xbqjUUrAHvEfNAUml0Fvi4Q863R5yxtWFBUY11lCZKTlEfPikvbHZUAkLwTUKrIX_6MEL8l9FlKNMJqJI7K_-rl2r8DgW9UDsidnEp7VKB-Qg-HJ5Mt0EA5P4Dnm1SDMBb8B5WZWQQ |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEY8LgvJaKBAQiEutJo6dxEgIlYVql3Z7gFbqzTiO3SJ1k6XZFeqf4jcyk8dSU9Fbb1E8cayZyczYmfmGkNcMFCG3cUoZs4JyYTjNU6ZpxBLNbRpqYbE4ebKXjA74l0NxuEJ-97UwmFbZ28TGUBeVwTPyTbCjWeNe5YfZT4pdo_Dvat9Co1WLHXv2C7Zs9fvxJ5DvG8a2P-8PR7TrKgCL4GxOuYlzmZoGOU5CwFxwy6W2wrlQ2LzQYeQydNTOCYvlhS7XNjIpcwLB2Y2LYd5r5DqP4xSx-rPhMqUkAm-bdcCQUZZsRmD4KTaAohGnyT8V9SeeI2z6BVz0Cufcop-yec4Hbt8ld7rgNdhqte0eWbHlGrnRtrM8WyM3J92P-vtkb7gEgm7rPIPKBVM82bfBVGPbsGMwZHWA1S1BXjV3EQ1yI6hnmNwR6LIIEIQZscIX0wfk4EqY_JCslvCCxyRIbZFInliQveEQHslEO-5gwiLKikjmA_LO46uatTAdCoGz_RHQJ4VCUSgUuFLJgNBeCMp0oOjYm-NENZujLLlA_3ZJ37_nf5QfUabeapob1emR6qyCskZraYzJcxFyHWY6k3gsLbTV2sUaJnmFGqEQqKPETKAjvahrNf72VW2JGGJfYG8Ka-qIXAVrN7orrAD2IbaXR7nuUYIlMf5wr3iqs2S1-vvdDcjL5TA-idl5pa0WLY2UAnanl9DE2NYG8zwG5FGry0vesDjOIKwPByT1tNxjnj9S_jhusNBjAbOK8MnlS39Bbo32J7tqd7y385TcZk1LE0ZDsU5W56cL-wwCy3n-vPmaA_L9qs3HHzuQi_0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfGEBMvCMZXYUBASLxglg87iXnbBlUHrELApGkvlu3Y20SbVGv7wH_PnZNGNRW88BbFFye6L5-du98R8joFRdA2K2iaWk4ZN4zqIlU0SXPFbBErbrE4-WScj07ZpzN-tkVGq1oYPTVXWBjhz5TfrZegT7zfhgvzc39Wudbcy3w_AfdKsc0STRjNb5CbBaJK4b798Lz_nwDroC-KW9F28I2bz_9R9z4JliuP6r_pu9cWrzCxcm2lGt4ld7oQMzpodeIe2bL1LrnVNp38tUt2Trrf6ffJ-KiHa26rMaPGRVM8f7fRVGFzr0twN_MIa1Ai3fi7iNn4NprPMAUjUnUVIVQyInovpw_I6fDjj6MR7RosgDxYuqDMZFoUxoPoCdg7VMwyoSx3LuZWVypOXIkxi3PcYqWl08ompkgdR5x647KHZLuGFzwmUWGrXLDcgjkbBkGMyJVjDiaskrJKhB6Q9wFf5awF05AIbx2OgJglCkWiUOBK5gNCV0KQpoMuxw4aE-m3MGW-Qf-mp1-952-UhyjT4Gv8jeb6Qna2K61RShhjtOYxU3GpSoGHx1xZpVymYJJXqBES4TRqzNe5UMv5XB5__yYPeAYRKrC3gG_qiFyDSqy68gdgHyJwBZR7ASXYuwmHV4onO38zlxBllD74FAPysh_GJzGHrrbNsqURgsMe8h80GTafwWyMAXnU6nLPmzTLSgi-4wEpAi0PmBeO1FeXHrE84zArj5_8jxK8IDtfPwzll-Px56fkduq7kqQ05ntke3G9tM8gNlzo597sfwOyHGCz |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+murine+macrophages+from+bone+marrow%2C+spleen+and+peritoneum&rft.jtitle=BMC+immunology&rft.au=Wang%2C+Changqi&rft.au=Yu%2C+Xiao&rft.au=Cao%2C+Qi&rft.au=Wang%2C+Ya&rft.date=2013-02-05&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2172&rft.eissn=1471-2172&rft.volume=14&rft_id=info:doi/10.1186%2F1471-2172-14-6&rft.externalDBID=ISR&rft.externalDocID=A534560947 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2172&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2172&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2172&client=summon |